Atrial fibrillation in hypertrophic cardiomyopathy - A contemporary mini-review
- PMID: 35584711
- DOI: 10.1016/j.hjc.2022.05.002
Atrial fibrillation in hypertrophic cardiomyopathy - A contemporary mini-review
Abstract
Hypertrophic cardiomyopathy (HCM) represents the most common genetically inherited cardiovascular disorder and a leading cause of heart failure and sudden cardiac death. Atrial fibrillation (AF) is the most common arrhythmia encountered in HCM patients, primarily due to the process of left atrium dilatation and remodeling. Its presence typically leads to progressive functional decline, increased frequency of heart failure hospitalizations, and increased thromboembolic risk. In this mini-review, we summarize the contemporary data on AF pathophysiology, risk factors, and management in HCM patients suffering from AF.
Keywords: Arterial thromboembolism; Atrial fibrillation; Hypertrophic cardiomyopathy.
Copyright © 2022 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflicts of Interest The authors declare no conflict of interest.
Similar articles
-
Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.ESC Heart Fail. 2021 Dec;8(6):5022-5030. doi: 10.1002/ehf2.13563. Epub 2021 Sep 2. ESC Heart Fail. 2021. PMID: 34472710 Free PMC article.
-
Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management.Heart Fail Rev. 2019 Mar;24(2):189-197. doi: 10.1007/s10741-018-9752-6. Heart Fail Rev. 2019. PMID: 30456592 Review.
-
Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.Clin Res Cardiol. 2021 Apr;110(4):544-554. doi: 10.1007/s00392-020-01730-w. Epub 2020 Sep 3. Clin Res Cardiol. 2021. PMID: 32880676
-
Hypertrophic Cardiomyopathy Predicts Thromboembolism and Heart Failure in Patients With Nonvalvular Atrial Fibrillation - A Prospective Analysis From the Hokuriku-Plus AF Registry.Circ J. 2023 Nov 24;87(12):1790-1797. doi: 10.1253/circj.CJ-23-0418. Epub 2023 Oct 20. Circ J. 2023. PMID: 37866911
-
Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.J Cardiovasc Electrophysiol. 2022 Jan;33(1):20-29. doi: 10.1111/jce.15304. Epub 2021 Dec 8. J Cardiovasc Electrophysiol. 2022. PMID: 34845799 Free PMC article.
Cited by
-
Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using plasma proteomics profiling.Europace. 2024 Nov 1;26(11):euae267. doi: 10.1093/europace/euae267. Europace. 2024. PMID: 39441047 Free PMC article.
-
Arrhythmias and Hypertrophic Cardiomyopathy: Unravelling the Connection.Curr Cardiol Rev. 2024;20(4):e240124226139. doi: 10.2174/011573403X279223231227111737. Curr Cardiol Rev. 2024. PMID: 38279754 Free PMC article. Review.
-
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication.J Clin Med. 2024 Jan 16;13(2):501. doi: 10.3390/jcm13020501. J Clin Med. 2024. PMID: 38256635 Free PMC article. Review.
-
Twenty-four hour variability of inverted T-waves in patients with apical hypertrophic cardiomyopathy.Front Cardiovasc Med. 2022 Sep 21;9:1004178. doi: 10.3389/fcvm.2022.1004178. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36211576 Free PMC article.
-
Complementary classification of hypertrophic cardiomyopathy using unsupervised cluster analysis on left ventricular function.Sci Rep. 2025 Mar 11;15(1):8362. doi: 10.1038/s41598-025-93202-2. Sci Rep. 2025. PMID: 40069297 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical